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S(D)MDMA and 5-HT Evoke Dissimilar Ionic Currents in Human
Serotonin Transporter-Expressing Cells
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Although monoamine transporters translocate substrates (neurotransmitters)
across the plasma membrane, a second less studied function is their ion
channel-like activity which is responsible for the passive permeation of ions
through the membrane. These currents are inward at resting membrane
potential and would result in cell depolarization, which may enhance presynap-
tic excitability, and which would help explain the elevated release of neuro-
transmitter associated by psychostimulants. Here we compare the ionic
currents evoked by serotonin (5-HT) and S(þ)-3,4-methylenedioxy-N-methyl-
amphetamine (S(þ)MDMA, ecstasy) in mammalian cells expressing the
human serotonin transporter (hSERT). 5-HT as well as S(þ)MDMA induce
inward currents in hSERT-expressing cells. Although the conductances are
similar, the S(þ)MDMA induced-current reversal potential is strongly shifted
towards the Naþ equilibrium potential, indicating a bigger contribution of Naþ
to the overall current compared to 5-HT current. To measure changes in Naþ
permeability induced by these compounds, the cells were pre-loaded with the
Naþ sensor Asante NaTRIUMGREEN 2 and changes in intracellular Naþ con-
centration ([Naþ]i) were monitored fluorometrically. Dose-response experi-
ments show that 5-HT and S(þ)MDMA have similar potency (EC50
~200 nM) in elevating the [Naþ]i; however, S(þ)MDMA increases [Naþ]i at
least 3 times with respect to 5-HT. In addition, the reconstitution of hSERT
on a lipid bilayer in the presence of a Naþ gradient showed channel-like activity
after the application of 5-HT or S(þ)MDMA in the trans side. Taken together
these results strongly suggest that S(þ)MDMA-induced current is different in
composition than the 5-HT current, and moreover it must be strongly depola-
rizing due to its higher Naþ content.
Supported by RC1DA028112 and R01DA033930.
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Is the Second Sodium Pump Electrogenic?
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Transepithelial sodium transport is a process that involves Naþ entry across the
apical membrane of the epithelial cell following its electrochemical gradient
and its active extrusion at the basolateral plasma membrane by two sodium
pumps: The Na/K-pump, which depends on Kþ, is inhibited by ouabain and
insensitive to furosemide; and the Second Sodium pump, which is Kþ-indepen-
dent, insensitive to ouabain but inhibited by furosemide (J. Gen. Physiol.
51:303s-314s, 1968; Pflu¨gers Archiv Eur J Physiol 316:1-25, 1970; Biochim
Biophys Acta 394:281-292, 1975). Both transport mechanisms are associated
with two ATPases present in the basolateral plasma membrane of the epithelial
cells with similar functional characteristics, the Naþ/Kþ-ATPase and the Naþ-
ATPase, respectively (Biochim Biophys Acta 1808:1684-1700, 2011; Pflu¨gers
Archiv Eur J Physio. 316:1-25, 2012). The Naþ/Kþ-pump is electrogenic; it
exchanges 3 internal Naþ by 2 external Kþ producing a net charge movement.
The Second pump transports Naþ with Cl and water. It has been suggested
that this pump could be electrogenic. The Naþ charge transfer would induce
Cl movement and osmotic movement of water following the movement of
both Naþ and Cl across the membrane. We have evaluated electrical param-
eters of the basolateral plasma membranes of MDCK cells cultured on Trans-
well in Ussing chambers, using amphotericin B as apical permeabilizing agent.
Our results confirm that the Naþ/Kþ-pump is electrogenic and that the Second
sodium pump is electroneutral, coupling the active Naþ transport to a specific
Cl movement through a particular conductive pathway.
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We disrupted the three conserved disulfide bonds in Xenopus b3 (C127C144,
C154-C170, C191-C248), one at a time, using Cys to Ala/Ser mutations and
coexpression with relatively ouabain-resistant (C113Y) Xenopus a1 in oocytes.
We assessed function with two-microelectrode voltage clamp in 1mM ouabain
to silence endogenous Na/K pumps. Single C127S/A or C154S, or double
C127SþC154S b3 mutants yielded steady Na/K pump currents (saturating
[Ko]) and transient Na charge movements (without Ko) like those of C113Y
a1 coexpressed with wild-type b3, suggesting that neither assembly, traffick-ing, nor Na/K pump function require intact first and/or second disulfide bonds.
In contrast, steady and transient pump currents were bothR10 fold smaller in
Na/K pumps with disrupted third disulfide bond after C113Y a1 coexpression
with C191A/S b3. Similarly, in outside-out excised patches, palytoxin-induced
pump-channel currents were R10 fold smaller for C113Y a1 Na/K pumps
coexpressed with b3 C191S than with wild-type b3. Because in uninjected
oocytes or oocytes expressing C113Y a1 alone, neither steady nor transient
pump current could be detected, and palytoxin elicited no measurable current
in outside-out patches, the third disulfide bond appears necessary for efficient
Na/K-ATPase assembly and trafficking to the cell membrane but is not essential
for assembled pump function.We disrupted salt bridges linking the aTM7-TM8
loop and b-exodomain inNa/K-ATPase structures (a1 E901-b3K219,a1 E911-
b3 R262), by coexpressing E901R(C113Y) or E911R(C113Y) a1 with wild-
type b3. In both mutants, steady Na/K pump currents (at saturating [Ko]) and
transient Na charge movements were like wild type; but the E901R a1 mutation
selectively enhanced apparent Ko affinity ~2 fold. These results suggest that
some b-exodomain structural alterations can be tolerated; but a-b subunit inter-
face interactions closely regulate Ko binding/occlusion steps, though not the
slow step that occludes/deoccludes the third Na ion. [HL36783]
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All proteins are synthesized in the cytoplasm. However, for many of them the
cytoplasm is not their final destination. Instead, they need to be translocated
across or into the plasma membrane. In bacteria, this process is mediated by
the membrane-embedded protein-conducting SecYEG channel. This channel
can either associate with the ribosome (co-translational translocation) or with
a cytosolic motor protein, the SecA ATPase (post-tranlational translocation),
with each the ability to provide the driving force for the translocation process
across the membrane.
Even though the SecYEG system has been intensively studied, many aspects of
protein translocation remain elusive. Here, we study translocation by single-
molecule fluorescence imaging. We reconstitute the bacterial SecYEG into
phospholipid bilayer nanodiscs and immobilize these on a functionalized
glass-surface. By monitoring the interactions of the components of the Sec
translocon at resolution of individual molecules we aim to provide a means
for better understanding the journey of proteins into or across the membrane.
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A major factor contributing to the therapeutic effectiveness of a drug is whether
it will be a substrate for efflux transporter proteins such as P-glycoprotein
(P-gp). P-gp is an ATP-binding cassette transporter that is able to expel a re-
markable range of therapeutic drugs from their target cells. Despite this, sur-
prisingly little is known about the mechanism with which it exports drugs.
Following drug binding within P-gp’s transmembrane domain (TMD) binding
cavity, export to the cell exterior is believed to be driven by ATP binding and/or
hydrolysis at the cytoplasmic nucleotide binding domains (NBDs). We have
been using atomistic molecular dynamics simulation to study the interactions
of experimentally characterized ligands with the binding cavity of P-gp and
their influence on P-gp NBD dynamics.
Available structures of P-gp display large separations of their NBDs. We ob-
served tighter association of the NBDs in our simulations even in the absence
of nucleotide. The degree of association and ATP binding site conformations
were dependent on whether substrate or inhibitor was bound in the TMD bind-
ing cavity. In addition, conformational changes in the binding cavity coupled
with ligand dynamics allowed formation of protein-ligand contacts that agreed
with previous mutational studies but could not be predicted from just the crystal
structure. Finally we explored the effects of ATP binding and hydrolysis to bet-
ter understand how this process is coupled to substrate transport.
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The IC50 for Inhibition of Digoxin Transport Across Confluent Cell
Monolayers of P-gp Expressing Cell Lines is Often a Function of Inhibitor
Binding to Both P-gp and an Unidentified Basolateral Digoxin Uptake
Transporter
Joe Bentz.
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Previously, we reported that the P-gp substrate digoxin requires basolateral and
apical uptake transporter(s) to achieve the observed efflux kinetics across
MDCKII-MDR1 (Netherlands Cancer Institute) confluent cell monolayers.
Sunday, February 3, 2013 111aWe extend this kinetic analysis to include other cell lines, including MDCKII-
MDR1 (National Institute of Health) and Caco-2. Digoxin transport across
confluent cell monolayers was measured in the absence and presence of several
P-gp substrates and/or inhibitors. Our kinetic analysis showed that digoxin
transport in these other cell lines typically requires a basolateral digoxin uptake
transporter. The B>A transport inhibition curve of digoxin was a conflation of
inhibitor binding to both P-gp and to this basolateral digoxin uptake transporter.
If a new compound is an inhibitor of digoxin transport across any of these cell-
lines, the IC50 could be due to binding to P-gp or to the basolateral digoxin
uptake transporter, or both. Finally, our analysis allowed us to estimate the
efflux active P-gp surface density on the cell lines, which is the fraction of
P-gp in the plasma membrane which successfully effluxes substrate into the
apical chamber, which depends upon microvilli morphology.
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Low Doses of a Combination of Curcumin with Ouabain or Gramicidin
Selectively Kill Cancer Cells that Express the Multidrug Resistance-
Linked ABCG2 Transporter
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The work presented here introduces a strategy to kill selectively multidrug
resistant (MDR) cancer cells that express the ABCG2 transporter (also called
breast cancer resistance protein, BCRP). The approach is based on specific
stimulation of ATP hydrolysis by ABCG2 transporters with sub-toxic doses
of curcumin combined with stimulation of ATP hydrolysis by the Naþ Kþ
ATPase with sub-toxic doses of ouabain or gramicidin A. The resulting over-
consumption of ATP by both pathways inhibits the efflux activity of ABCG2
transporters and leads to depletion of intracellular ATP levels below the viabil-
ity threshold. In contrast, cells without the ABCG2 transporter lack one path-
way and maintain viability at basal ATP levels. Similar results were obtained
with a clinically relevant human breast adenocarcinoma cell line that expresses
ABCG2 transporters (MCF-7/FLV1) and its parental cell line (MCF-7). This
strategy, which is based on compounds that are currently in clinical use, ex-
ploits the overexpression of ABCG2 transporters in cancer cells by accelerating
their ATP hydrolysis rate to kill selectively those cells which are particularly
resistant to conventional chemotherapy. This work introduces a novel strategy
to exploit collateral sensitivity (CS) with a combination of two compounds that,
individually, do not exert CS. It also demostrates that the mechanism for CS is
necrotic cell death induced by depletion of ATP below 50% of basal intracel-
lular levels. Since ABCG2 transporters are a putative marker for cancer stem
cells (CSCs), this approach may allow targeting CSCs.
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Gramicidin Currents Report P-Glycoprotein in Patch Clamp Recordings
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P-glycoprotein (P-gp), a member of the ATP binding cassette (ABC) trans-
porter family, actively excludes chemotherapeutics leading to reduced efficacy
of these agents, and the phenomenon of multidrug resistance (MDR) in cancer
cells. Thus, development of functional assays to better characterize P-gp and
minimize MDR is important for cancer therapy. Previous report demonstrated
that efflux of gramicidin D, a pore-forming antibiotic peptide, by P-gp reduced
pore formation, resulting in decreased cellular accumulation of 86Rbþ. This re-
sult suggested that gramicidin D is a substrate of P-gp [1]. This work presented
here establishes a novel approach to monitor the efflux activity of P-gp directly
and in real time. This approach takes advantage of the single molecule sensitiv-
ity of patch clamp techniques to measure currents through pores of the ion
channel forming peptide, gramicidin A (gA), which is also a substrate of
P-gp. Therefore, changes in whole cell gA currents directly report the efflux
of gA by P-gp. For instance, parental cells that do not express P-gp show whole
cell gA currents in a dose dependent manner, whereas resistant cells that over-
express P-gp show significantly reduced gA currents. P-gp inhibitors restore gA
currents to the level comparable to that in parental cells, which provides the
ability to screen for competitive inhibitor of P-gp. In addition, this assay pro-
vides easy access to extracellular and intracellular solution, and direct control
of cell membrane potential and intracellular concentration of molecules such as
ATP and Ca2þ. Results demonstrate that membrane depolarization enhances
the activity of P-gp while hyperpolarization reduces P-gp activity.
Reference:
1.Assaraf, Y.G. and M.J. Borgnia, Probing the interaction of the multidrugre-
sistance phenotype with the polypeptide ionophore gramicidin D via functional
channel formation. Eur J Biochem, 1994. 222(3): p. 813-24.573-Pos Board B342
Regulation of NBCe1-B by IRBIT, PIP2 and the WNK/SPAK Kinases
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The electrogenic Naþ-HCO3
 co-transporter NBCe1-B plays a crucial role in
pHin regulation and epithelial HCO3
 secretion by mediating basolateral
HCO3
 entry, when the luminal HCO3
 exit mediated by CFTR and members
of the SLC26 transporters.
The regulation of NBCe1-B is poorly understood. IRBIT, (inositol 1,4,5-tri-
sphosphate receptor binding protein released with IP3), binds to N terminus
of NBCe1-B to markedly increase its activity, while the WNK/SPAK pathway
setting the resting state by reducing surface expression of NBCe1-B. NBCe1-B
may also be regulated by PIP2 interacting with highly charge module in the N
terminus. The site and mechanisms for the regulation by IRBIT, PIP2, and
SPAK and the relationship between them are not known.
We identified a positive clustered module in NBCe1-B and three arginines
within required for regulation by IRBIT and PIP2. The effect of IRBIT and
PIP2 are not additive but complementary. The module contains two critical
phosphorylation sites. The constitutively cAMP phosphorylated Thr49 is re-
quired for all form of NBCe1-B regulations, while Ser65 mediates the function
of SPAK. The module is conserved in most NBC superfamily and have the
same roles in NBCn1-A. These findings suggest the sites of regulation on
NBCe1-B by IRBIT/PIP2 and SPAK and provide a molecular mechanism by




Structural Mechanism of Action of Binding Protein Independent Mutant
MalG511 of Escherichia Coli Maltose Transporter
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ATP-binding cassette (ABC) transporters couple the uphill transport of sub-
stances to the hydrolysis of ATP. Mutations in the E. coli maltose ABC trans-
porter have been isolated that allow transport in the absence of periplasmic
maltose binding protein (MBP), a protein that delivers maltose to the trans-
porter with high affinity and stimulates the ATPase activity of the transporter.
One such mutant, MalG511, shows an interesting biphasic behavior with low
levels of MBP stimulating transport activity while higher levels (>50mM)
inhibit transport activity. Remarkably, the rescuing effect of MBP suppressor
mutants isolated at high, inhibitory MBP concentrations provided insight into
regulatory mechanisms in the ABC transporter superfamily. Site directed
spin labeling EPR spectroscopy was used to follow the catalytic cycle of
MalG511 without any binding protein, with MBP and with suppressor MBP
by attaching spin label at two positions in the MalK ATPase subunit (V16
and R129) that can be used to detect the closure of nucleotide-binding interface.
MalG511 responded differently to the addition of ligands, including nucleotide
and MBP, than wild type transporter. Notably, MalG511 can sample all confor-
mational states (open, semi-open and closed interface) in the absence of MBP,
as expected for a MBP-independent transporter. However, the closed state
could be stabilized only in the presence of a transition state analogue (vanadate)
suggesting that the mutations in MalG511 altered the conformational equilib-
rium of the transporter, favoring a semi-open over a closed conformation,
even in the presence of ATP, plus or minus MBP. The addition of MBP, but
not suppressor MBP, also resulted in a failure of the transporter to return to
the fully open state at the end of a catalytic cycle, suggesting a mechanism
for inhibition of transport at high MBP concentration.
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Transport Responses in the Sodium-Coupled Neutral Amino Acid
Transporter, SNAT2
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Sodium dependent neutral amino acid transporter (SNAT) 2, a member of the
solute carrier (SLC) 38 family, system A, mediates the coupled transport of
sodium and small neutral amino acids across a cell’s membrane. There has
been proposed structural homology between SNAT2 and the sodium/betaine
symporter, BetP. We mutated two conserved amino acids that have been shown
